Costs of telaprevir-based triple therapy for hepatitis C: $189,000 per sustained virological response-Reference-Cited by-同舟云学术

Costs of telaprevir-based triple therapy for hepatitis C: $189,000 per sustained virological response

Published:2014-08-25 Issue:4 Volume:60 Page:1187-1195
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Bichoupan Kian¹,Martel-Laferriere Valerie¹,Sachs David²,Ng Michel¹,Schonfeld Emily A.¹,Pappas Alexis¹,Crismale James¹,Stivala Alicia¹,Khaitova Viktoriya¹,Gardenier Donald¹,Linderman Michael²,Perumalswami Ponni V.¹,Schiano Thomas D.¹,Odin Joseph A.¹,Liu Lawrence¹,Moskowitz Alan J.³,Dieterich Douglas T.¹,Branch Andrea D.¹

Affiliation:

1. Division of Liver Diseases; Icahn School of Medicine at Mount Sinai; New York NY

2. Genetics and Genomics; Icahn School of Medicine at Mount Sinai; New York NY

3. Health Evidence and Policy; Icahn School of Medicine at Mount Sinai; New York NY

Publisher

Wiley

Subject

Hepatology

Reference53 articles.

1. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002;Armstrong;Ann Intern Med,2006

2. Hepatitis C virus infection in USA: an estimate of true prevalence;Chak;Liver Int,2011

3. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence;Mohd Hanafiah;Hepatology,2013